FDx Advisors’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-5,863
| Closed | -$536K | – | 629 |
|
2023
Q2 | $536K | Buy |
5,863
+3,102
| +112% | +$284K | 0.03% | 433 |
|
2023
Q1 | $231K | Hold |
2,761
| – | – | 0.01% | 659 |
|
2022
Q4 | $231K | Sell |
2,761
-360
| -12% | -$30.1K | 0.01% | 659 |
|
2022
Q3 | $302K | Sell |
3,121
-4,646
| -60% | -$450K | 0.01% | 552 |
|
2022
Q2 | $816K | Buy |
+7,767
| New | +$816K | 0.03% | 358 |
|
2022
Q1 | – | Sell |
-3,609
| Closed | -$584K | – | 826 |
|
2021
Q4 | $584K | Sell |
3,609
-2,603
| -42% | -$421K | 0.02% | 490 |
|
2021
Q3 | $926K | Buy |
6,212
+361
| +6% | +$53.8K | 0.03% | 356 |
|
2021
Q2 | $1.43M | Buy |
5,851
+996
| +21% | +$244K | 0.05% | 257 |
|
2021
Q1 | $1.29M | Buy |
4,855
+1,405
| +41% | +$372K | 0.05% | 242 |
|
2020
Q4 | $1.01M | Buy |
3,450
+602
| +21% | +$177K | 0.04% | 264 |
|
2020
Q3 | $673K | Buy |
+2,848
| New | +$673K | 0.03% | 310 |
|
2019
Q3 | – | Sell |
-5,345
| Closed | -$649K | – | 629 |
|
2019
Q2 | $649K | Buy |
+5,345
| New | +$649K | 0.03% | 426 |
|